These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15612274)

  • 1. General principles for risk assessment of living modified organisms: lessons from chemical risk assessment.
    Hill RA; Sendashonga C
    Environ Biosafety Res; 2003; 2(2):81-8. PubMed ID: 15612274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When Policy Meets Practice: The Dilemma for Guidance on Risk Assessment Under the Cartagena Protocol on Biosafety.
    Hokanson KE
    Front Bioeng Biotechnol; 2019; 7():82. PubMed ID: 31119127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory framework for genetically modified organisms in the Kingdom of Eswatini.
    Nkhabindze BZ; Magagula CN; Earnshaw D; Mhlanga CF; Matsebula SN; Dladla IG
    GM Crops Food; 2024 Dec; 15(1):212-221. PubMed ID: 38963885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conservation biology, genetically modified organisms, and the biosafety protocol.
    Hill R; Sendashonga C
    Conserv Biol; 2006 Dec; 20(6):1620-5. PubMed ID: 17181797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The OECD Blue Book on Recombinant DNA Safety Considerations: it's influence on ISBR and EFSA activities.
    Schiemann J
    Environ Biosafety Res; 2006; 5(4):233-5. PubMed ID: 17640515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory considerations in the development and application of biotechnology in Japan.
    Yamanouchi K
    Rev Sci Tech; 2005 Apr; 24(1):109-15. PubMed ID: 16110881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The organization for economic cooperation and development: challenges for risk assessment.
    McCammon SL
    Environ Biosafety Res; 2006; 5(4):239-43. PubMed ID: 17640517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of the OECD on the development of national/international risk/safety assessment frameworks.
    Gaugitsch H
    Environ Biosafety Res; 2006; 5(4):219-22. PubMed ID: 17640512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Genetically Modified Organism Medicinal Framework in Europe, United States, and Japan: Underlying Scientific Principles and Considerations Toward the Development of Gene Therapy and Genetically Modified Cell-Based Products.
    Bachtarzi H; Farries T
    Hum Gene Ther Clin Dev; 2019 Sep; 30(3):114-128. PubMed ID: 31111736
    [No Abstract]   [Full Text] [Related]  

  • 11. Under the Cartagena Protocol on Biosafety - Where is the Roadmap for Risk Assessment Taking Us?
    Gaugitsch H
    Front Bioeng Biotechnol; 2015; 3():212. PubMed ID: 26835448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations from the workshop on Comparative Approaches to Safety Assessment of GM Plant Materials: A road toward harmonized criteria?
    Bartholomaeus A; Batista JC; Burachik M; Parrott W
    GM Crops Food; 2015; 6(2):69-79. PubMed ID: 25706477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent development in the field of international liability regimes to tackle environmental risks.
    Bally J
    Water Sci Technol; 2005; 52(6):51-7. PubMed ID: 16304934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emerging international regulatory framework for biotechnology.
    Komen J
    GM Crops Food; 2012; 3(1):78-84. PubMed ID: 22430851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory considerations on transgenic livestock in Japan in relation to the Cartagena protocol.
    Yamanouchi K
    Theriogenology; 2007 Jan; 67(1):185-7. PubMed ID: 17055568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Cartagena Protocol on Biosafety: interaction between the Convention on Biological Diversity and the World Organisation for Animal Health.
    Sendashonga C; Hill R; Petrini A
    Rev Sci Tech; 2005 Apr; 24(1):19-30. PubMed ID: 16110874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Science, biopolitics and risk: margins of uncertainty.
    Krimsky S
    Politics Life Sci; 1989 Feb; 7(2):140-2, 149-53. PubMed ID: 17124765
    [No Abstract]   [Full Text] [Related]  

  • 18. Sources, pathways, and relative risks of contaminants in surface water and groundwater: a perspective prepared for the Walkerton inquiry.
    Ritter L; Solomon K; Sibley P; Hall K; Keen P; Mattu G; Linton B
    J Toxicol Environ Health A; 2002 Jan; 65(1):1-142. PubMed ID: 11809004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Important points in virus research using recombinant DNA technology].
    Nikaido T; Takeuchi K
    Uirusu; 2007 Jun; 57(1):91-100. PubMed ID: 18040159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Need for an "integrated safety assessment" of GMOs, linking food safety and environmental considerations.
    Haslberger AG
    J Agric Food Chem; 2006 May; 54(9):3173-80. PubMed ID: 16637668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.